Micell Technologies announced four-year clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent sirolimus eluting absorbable...
Positive data from two clinical studies of MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System indicates that it may provide...
Boston Scientific has received FDA approval for the Synergy Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary...
Micell Technologies,Inc. announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer...
The DESSOLVE I and II clinical trials using the MiStent SES (sirolimus eluting stent), from Micell Technologies, in patients with...
Boston Scientific reported positive, long-term data from the EVOLVE Trial of the Synergy Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium Coronary Stent...
Researchers have presented data from the independent BIO-RESORT study comparing the safety and efficacy of biodegradable polymer stents to Resolute...
A randomized comparison of the Combo Dual Therapy Stent, from Orbus Neich, which combines low-dose sirolimus delivery from an abluminal...
Boston Scientific announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting stent trial in the superficial femoral...
Researchers have found that the Cre8 polymer-free amphilimus-eluting stents, from Carbostent and Implantable Devices(CID), in de novo coronary artery lesions...